Please use this identifier to cite or link to this item:
Title in Portuguese: Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types Iand II bipolar disorder
Author: Maes, Michael
Bonifacio, Kamila Landucci
Morelli, Nayara Rampazzo
Vargas, Heber Odebrecht
Barbosa, Décio Sabbatini
Carvalho, André F.
Nunes, Sandra Odebrecht Vargas
Keywords: Depressão
Bipolar Disorder
Transtorno Bipolar
Issue Date: Apr-2018
Publisher: Molecular Neurobiology
Citation: MAES, M. et al. Major differences in neurooxidative and neuronitrosative stress pathways between major depressive disorder and types Iand II bipolar disorder. Molecular Neurobiology, New York, p. 1-6, apr. 2018.
Abstract: Accumulating evidence indicates that oxidative and nitrosative stress (O&NS) pathways play a key role in the pathophysiology of bipolar disorder (BD) and major depressive disorder (MDD). However, only a handful of studies have directly compared alterations in O&NS pathways among patients with MDD and BD types I (BPI) and BPII. Thus, the current study compared superoxide dismutase (SOD1), lipid hydroperoxides (LOOH), catalase, nitric oxide metabolites (NOx), malondialdehyde (MDA), and advanced oxidation protein products (AOPP) between mood disorder patients in a clinically remitted state. To this end 45, 23, and 37 participants with BPI, BPII, and MDD, respectively, as well as 54 healthy controls (HCs) were recruited. Z- unit weighted composite scores were computed as indices of reactive oxygen species (ROS) production and nitro-oxidative stress driving lipid or protein oxidation. SOD1, NOx, and MDAwere significantly higher in MDD than in the other three groups. AOPP was significantly higher in BPI than in HCs and BPII patients. BPII patients showed lower SOD1 compared to all other groups. Furthermore, MDD was characterized by increased indices of ROS and lipid hydroperoxide production compared to BPI and BPII groups. Indices of nitro-oxidative stress coupled with aldehyde production or protein oxidation were significantly different among the three patient groups (BDII > BDI > MDD). Finally, depressive symptom scores were significantly associated with higher LOOH and AOPP levels. In conclusion, depression is accompanied by increased ROS production, which is insufficiently dampened by catalase activity, thereby increasing nitro-oxidative damage to lipids and aldehyde production. Increased protein oxidation with formation of AOPP appeared to be hallmark of MDD and BPI. In addition, patients with BPII may have protection against the damaging effects of ROS including lipid peroxidation and aldehyde formation. This study suggests that biomarkers related to O&NS could aid in the differentiation of MDD, BPI, and BPII.
metadata.dc.type: Artigo de Periódico
ISSN: 0893-7648
1559-1182 (Online)
Appears in Collections:PPGSP - Artigo publicado em revista científica

Files in This Item:
File Description SizeFormat 
2018_art_mmaes.pdf846,47 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.